Pharmacokinetics of Aztreonam in Patients with Chronic Renal Failure

[1]  D. Spyker,et al.  Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction , 1983, Antimicrobial Agents and Chemotherapy.

[2]  H. Neu,et al.  Pharmacology of aztreonam after intravenous infusion , 1983, Antimicrobial Agents and Chemotherapy.

[3]  E. Swabb,et al.  Renal handling of the monobactam azthreonam in healthy subjects , 1983, Clinical pharmacology and therapeutics.

[4]  E. Swabb,et al.  Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects , 1982, Antimicrobial Agents and Chemotherapy.

[5]  G. Bodey,et al.  Comparative in vitro study of SQ26,776 , 1982, Antimicrobial Agents and Chemotherapy.

[6]  K. Bush,et al.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria , 1982, Antimicrobial Agents and Chemotherapy.

[7]  I. Phillips,et al.  Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases. , 1982, The Journal of antimicrobial chemotherapy.

[8]  H. Neu,et al.  Antibacterial activity of a monocyclic β-lactam SQ 26,776 , 1981 .

[9]  R. Wise,et al.  SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents. , 1981, The Journal of antimicrobial chemotherapy.

[10]  D. Reeves,et al.  Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp. , 1981, The Journal of antimicrobial chemotherapy.

[11]  D. Perrier,et al.  Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability , 1978, Clinical pharmacology and therapeutics.

[12]  A. Karim.  The pharmacokinetics of Norpace. , 1975, Angiology.